Tower Research Capital LLC (Trc) Dynavax Technologies Corp Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,892 shares of DVAX stock, worth $43,045. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,892
Previous 16,239
76.03%
Holding current value
$43,045
Previous $161,000
76.4%
% of portfolio
0.0%
Previous 0.0%
Shares
32 transactions
Others Institutions Holding DVAX
# of Institutions
303Shares Held
120MCall Options Held
293KPut Options Held
311K-
Black Rock Inc. New York, NY21.9MShares$242 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT15.7MShares$174 Million4.93% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.1MShares$89.6 Million0.0% of portfolio
-
State Street Corp Boston, MA6.29MShares$69.5 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.53MShares$50.1 Million0.02% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.4B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...